Form 4: USANA Health Sciences Insider Sells Shares
Statement of Changes in Beneficial Ownership
USANA Health Sciences Chief Commercial Officer, Brent Neidig, reported the sale of company stock on June 12th and June 15th, 2026.
Summary
- Brent Neidig, Chief Commercial Officer of USANA Health Sciences Inc. (USNA), has reported transactions involving the sale of company stock.
- On June 12, 2026, Neidig sold 1,602 shares of common stock at a price of $20.15 per share.
- On June 15, 2026, an additional 909 shares of common stock were sold at a price of $20.005 per share.
- Following these transactions, Neidig beneficially owns 5,002 shares of common stock directly.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing as having a slightly negative sentiment due to insider selling, though the absence of financial performance data limits a more definitive assessment.
Negatives
- Insider selling activity can sometimes be interpreted negatively by the market, suggesting a lack of confidence from management in future stock performance, although this is not always the case.
Future Outlook
No forward-looking statements or guidance are present in this filing.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. While this filing details stock sales by a key executive, it does not provide operational or financial performance data, making it difficult to assess broader industry trends or competitive positioning based solely on this document.
Stakeholder Impact
- Shareholders may view the insider selling with caution, potentially impacting short-term stock sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/12/2026 | Earliest transaction date reported and date of first stock sale. |
| 06/15/2026 | Date of second stock sale. |
| 06/16/2026 | Date of signature on the filing. |
Recommendation
holdThe filing reports insider stock sales by a key executive. While this can be a negative signal, the absence of financial performance data or strategic updates prevents a strong buy or sell recommendation. A 'hold' position allows for further monitoring of the company's performance and management's rationale for the sales.
Keywords
USANA Health Sciences, USNA, Form 4, Insider Trading, Stock Sale, Beneficial Ownership, Brent Neidig, Chief Commercial Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.